Stay updated on SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Sign up to get notified when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, replacing the study content with an access-denied screen. This indicates a site access issue rather than a change to the study information itself.
    Difference
    18%
    Check dated 2026-09-23T00:06:42.000Z thumbnail image
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision updated to v3.7.0 in the Study Documents section, replacing the previous v3.6.6. This reflects an updated set of trial documents.
    Difference
    0.0%
    Check dated 2026-09-16T00:08:10.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    Change Detected
    Summary
    The page's revision label was updated to v3.6.6, replacing the previous v3.6.5. This indicates a minor maintenance update without changes to study details or patient-facing information.
    Difference
    0.0%
    Check dated 2026-09-01T19:13:27.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    Adds a new funding identifier: '2017 ( U.S. NIH Grant/Contract )'. This expands the list of study identifiers with a funding source reference associated with the trial record.
    Difference
    0.0%
    Check dated 2026-08-25T20:07:48.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, indicating a new deployment of the page template. No study content or visible information appears to have changed.
    Difference
    0.0%
    Check dated 2026-08-11T19:51:48.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page revision label changed from v3.6.3 to v3.6.4, indicating a backend update to the page. No study data, details, or actionable content were altered.
    Difference
    0.0%
    Check dated 2026-07-21T13:41:50.000Z thumbnail image

Stay in the know with updates to SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the SafetyEfficacy SGN-LIV1A+Pembrolizumab in TNBC Clinical Trial page.